Uridine 5′-diphosphoglucose-13C6 disodium

Modify Date: 2024-01-12 12:43:48

Uridine 5′-diphosphoglucose-13C6 disodium structure	Common Name	Uridine 5′-diphosphoglucose-13C6 disodium
	CAS Number	2483735-04-0	Molecular Weight	590.21
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₉₁₃C₆H₁₉N₂NaO₁₇P₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Uridine 5′-diphosphoglucose-13C6 disodium

Uridine 5′-diphosphoglucose-13C6 (disodium) is the 13C labeled Uridine 5′-diphosphoglucose disodium salt[1]. Uridine 5′-diphosphoglucose disodium salt (UDP-D-Glucose disodium salt) is the precursor of glucose-containing oligosaccharides, polysaccharides, glycoproteins, and glycolipids in animal tissues and in some microorganisms. Uridine-5′-diphosphoglucose is an agonist of the P2Y14 receptor, a neuroimmune system GPCR[2].

Name	Uridine 5′-diphosphoglucose-13C6 disodium

Description	Uridine 5′-diphosphoglucose-13C6 (disodium) is the 13C labeled Uridine 5′-diphosphoglucose disodium salt[1]. Uridine 5′-diphosphoglucose disodium salt (UDP-D-Glucose disodium salt) is the precursor of glucose-containing oligosaccharides, polysaccharides, glycoproteins, and glycolipids in animal tissues and in some microorganisms. Uridine-5′-diphosphoglucose is an agonist of the P2Y14 receptor, a neuroimmune system GPCR[2].
Related Catalog	Signaling Pathways >> GPCR/G Protein >> P2Y Receptor Research Areas >> Neurological Disease
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. DietrichKeppler, et al. Uridine-5′-diphosphoglucose. Methods of Enzymatic Analysis (Second English Edition). 1974;4:2225-2228. [3]. Das A, et al. Human P2Y(14) receptor agonists: truncation of the hexose moiety of uridine-5'-diphosphoglucose and its replacement with alkyl and aryl groups. J Med Chem. 2010 Jan 1453(1):471-80.

Molecular Formula	C₉₁₃C₆H₁₉N₂NaO₁₇P₂
Molecular Weight	590.21

Uridine 5′-diphosphoglucose-13C6 disodium

Use of Uridine 5′-diphosphoglucose-13C6 disodium

Names

Biological Activity

Chemical & Physical Properties